Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.50
Delayed Data
As of 3:59pm ET
 -0.01 / -0.40%
Today’s Change
2.00
Today|||52-Week Range
7.15
+4.17%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.51
Today’s open2.51
Day’s range2.47 - 2.57
Volume56,696
Average volume (3 months)138,778
Market cap$28.9M
Data as of 3:59pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc-0.09-1.27%
CDMOPAvid Bioservices Inc0.000.00%
TCONTRACON Pharmaceutica...-0.30-9.84%
AMPEAmpio Pharmaceutical...0.000.00%
Data as of 4:10pm ET, 01/19/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$3.90
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Secretary, Chief Legal &
Compliance Officer, SVP
Kenneth R. Piña
Corporate headquarters
Morristown, New Jersey

Forecasts